ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2025-03-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2025-03-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2025-03-31..
Borrowing debt
Overview →Financial period ending 2025-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2025-03-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2025-03-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2025-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 15.00M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 331.79M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | (m) | (m) | (m) | $15.00M | (m) | (m) | $331.79M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $20.00M | (m) | (m) | $457.65M | (m) |
| 2022-12-31 | (m) | (m) | $60.66M | (m) | (m) | (m) | $450.39M | (m) |
| 2022-09-30 | (m) | (m) | $27.70M | $32.04M | (m) | (m) | $293.63M | (m) |
| 2022-06-30 | (m) | (m) | $27.02M | $35.76M | (m) | (m) | $337.01M | (m) |
| 2022-03-31 | (m) | (m) | $24.26M | $39.23M | (m) | (m) | $341.99M | (m) |
| 2021-12-31 | (m) | (m) | $22.47M | $40.63M | (m) | (m) | $392.81M | (m) |
| 2021-09-30 | (m) | (m) | $18.48M | $42.34M | (m) | (m) | $434.54M | (m) |
| 2021-06-30 | (m) | (m) | $5.00M | $56.31M | (m) | (m) | $448.81M | (m) |
| 2021-03-31 | (m) | (m) | $3.13M | $58.15M | (m) | (m) | $481.47M | (m) |
| 2020-12-31 | (m) | (m) | $1.25M | $13.85M | (m) | (m) | $476.46M | (m) |
| 2020-09-30 | (m) | (m) | (m) | $15.08M | (m) | (m) | $322.52M | (m) |
| 2020-06-30 | (m) | (m) | (m) | $15.06M | (m) | (m) | $149.94M | (m) |
| 2020-03-31 | (m) | (m) | (m) | $15.03M | (m) | (m) | $72.10M | (m) |
| 2019-12-31 | (m) | (m) | (m) | $14.99M | (m) | (m) | $82.14M | (m) |
| 2019-09-30 | (m) | (m) | (m) | $10.02M | (m) | (m) | $87.22M | (m) |
| 2019-06-30 | (m) | (m) | (m) | $9.98M | (m) | (m) | $70.94M | (m) |
| 2018-12-31 | (m) | (m) | (m) | $9.91M | (m) | (m) | $44.20M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |